FIB-4 index shows limited accuracy for individual MASLD patients. Learn more about its role and challenges in liver fibrosis screening.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Liver fibrosis scores (LFSs) are novel tools for predicting cardiovascular events in patients with ...

Reliance on FIB-4 screening tool alone may not identify some patients with significant fib ...

Background Metabolic-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease affecting approximately ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Aldafermin 3 mg and 1 mg reduced Enhance Liver Fibrosis ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The diagnostic performance of fibrosis-4 index and NAFLD ...

Non-invasive biomarkers and scoring systems demonstrated effectiveness in differentiating chronic liver disease (CLD) from cirrhosis; non-invasive fibrosis scores such as the Lok index, King's score, ...

The use of Agile scores based on vibration-controlled transient elastography (VCTE) accurately predicted liver-related events in patients with metabolic dysfunction-associated steatotic liver disease ...

Liver fibrosis may be diagnosed and staged — no fibrosis (stage F0), mild fibrosis (F1), significant fibrosis (F2), advanced fibrosis (F3), and cirrhosis (F4) — with the use of clinical parameters and ...